These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 2870837

  • 1. [Efficacy of the nadolol-bendroflumethiazide combination in the treatment of arterial hypertension].
    Zecchi P, Bellocci F, Santarelli P, Iannarelli M.
    Clin Ter; 1986 Jan 15; 116(1):19-24. PubMed ID: 2870837
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of essential arterial hypertension with nadolol and bendroflumethiazide].
    Marchetta F, Chiarini C, Degli Esposti E, Santoro A, Sturani A, Zuccalà A, Zucchelli P.
    Clin Ter; 1983 Aug 15; 106(3):209-12. PubMed ID: 6627892
    [No Abstract] [Full Text] [Related]

  • 3. [Nadolol + bendroflumethiazide in a fixed combination and in sequential administration. Experimental research on antihypertensive efficacy and tolerability].
    Del Re ML, Ricci A, Abate G.
    Clin Ter; 1986 Mar 15; 116(5):385-90. PubMed ID: 2871962
    [No Abstract] [Full Text] [Related]

  • 4. [Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo].
    Cherchi A, Sau F, Mercuro G, Seguro C, Lai O.
    Clin Ter; 1985 May 31; 113(4):301-6. PubMed ID: 3893868
    [No Abstract] [Full Text] [Related]

  • 5. [Combined treatment of arterial hypertension. Comparison of a beta-blocker plus a saluretic combination with beta-blocker].
    Rodatz KW, Hörder MH.
    MMW Munch Med Wochenschr; 1983 Feb 18; 125(7):136-8. PubMed ID: 6133217
    [No Abstract] [Full Text] [Related]

  • 6. Nadolol, a once daily treatment for hypertension: multi-centre clinical evaluation.
    Jackson DA.
    Br J Clin Pract; 1980 Jul 18; 34(7):211-21. PubMed ID: 6107120
    [No Abstract] [Full Text] [Related]

  • 7. A long-term evaluation of nadolol, a long-acting beta-adrenergic blocking agent, in the management of hypertension in general practice.
    O'Callaghan EG.
    Br J Clin Pract; 1982 Jun 18; 36(6):235-9. PubMed ID: 6128994
    [No Abstract] [Full Text] [Related]

  • 8. [Evaluation of the antihypertensive effect and tolerability of nadolol administered alone or in association with bendroflumethiazide].
    Gragnoli G, Righi GA, Turchetti V, Mondillo S, Kristodhullu A.
    Minerva Med; 1984 Nov 10; 75(43):2609-15. PubMed ID: 6392936
    [Abstract] [Full Text] [Related]

  • 9. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
    Hill LS, Fand RS.
    Ir Med J; 1979 Dec 10; 72(12):522-9. PubMed ID: 44273
    [No Abstract] [Full Text] [Related]

  • 10. [Our experience on the clinical use of nadolol].
    Trinchero R, Moratti M, Ghisio A, Pomari F, Artesani S, Barbano G.
    Minerva Cardioangiol; 1985 Oct 10; 33(10):629-34. PubMed ID: 2867492
    [No Abstract] [Full Text] [Related]

  • 11. Nadolol (corgard) in severe and resistant hypertension.
    Nontak MA.
    Med J Malaysia; 1981 Sep 10; 36(3):181-5. PubMed ID: 6120443
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical evaluation of the hypotensive effects of nadolol].
    Hanzlik J, Sodolski W, Stelmasiak T, Wolański I.
    Kardiol Pol; 1982 Sep 10; 25(2):101-6. PubMed ID: 6125620
    [No Abstract] [Full Text] [Related]

  • 13. Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic.
    Freis ED.
    Am Heart J; 1984 Oct 10; 108(4 Pt 2):1087-91. PubMed ID: 6148868
    [Abstract] [Full Text] [Related]

  • 14. [Celiprolol efficacy and tolerance in the treatment of arterial hypertension].
    Lobos Bejarano JM, Granados Menéndez MI, del Valle González J, Bravo Juega P.
    An Med Interna; 1991 Jan 10; 8(1):52-3. PubMed ID: 1680475
    [No Abstract] [Full Text] [Related]

  • 15. Nadolol (Corgard) - a new beta-blocker.
    Med Lett Drugs Ther; 1980 Apr 18; 22(8):33-4. PubMed ID: 6102734
    [No Abstract] [Full Text] [Related]

  • 16. Mediation of blood pressure by nadolol and alpha methyldopa.
    Jenkins AC, Rosenthal J, Stumpe KO.
    Practitioner; 1981 Mar 18; 225(1353):405-9. PubMed ID: 6115378
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of nadolol in angina pectoris.
    Cruz J, Conceicao JM, Coelho EM.
    Practitioner; 1982 Aug 18; 226(1370):1452-3. PubMed ID: 6127670
    [No Abstract] [Full Text] [Related]

  • 18. Prorenin and beta-blockade in hypertension.
    McKenna F, Davison AM.
    Proc Eur Dial Transplant Assoc; 1983 Aug 18; 20():566-71. PubMed ID: 6140678
    [Abstract] [Full Text] [Related]

  • 19. [Antihypertensive therapy with a fixed combination of beta receptor blockers and diuretics].
    Kolloch R, Overlack A, Stumpe KO.
    Ther Ggw; 1979 Oct 18; 118(10):1517-28. PubMed ID: 40314
    [No Abstract] [Full Text] [Related]

  • 20. Nadolol: a new beta-adrenoceptor antagonist.
    Frishman WH.
    N Engl J Med; 1981 Sep 17; 305(12):678-82. PubMed ID: 6115316
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.